Progestin-only contraception and venous thromboembolism

Thrombosis Research

Volumn 129, Issue 5, 2012, Pages

  Blanco Molina, M A ^a   Lozano, M ^b   Cano, A ^c   Cristobal, I ^d   Pallardo, L P ^e   Lete, I ^f  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c Gynecology Department   (Spain)

^d Hospital de la Zarzuela   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f HOSPITAL TXAGORRITXU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; CHLORMADINONE ACETATE; COMBINED ORAL CONTRACEPTIVE; ETHINYLESTRADIOL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORGESTREL; ORAL CONTRACEPTIVE AGENT; PROTHROMBIN; UNCLASSIFIED DRUG;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ANTITHROMBIN DEFICIENCY; ARTICLE; BLOOD CLOTTING; CARDIOVASCULAR RISK; HEART INFARCTION; HEMOSTASIS; HORMONAL CONTRACEPTION; HUMAN; HYPERCOAGULABILITY; INTERNATIONAL NORMALIZED RATIO; INTRAUTERINE CONTRACEPTIVE DEVICE; ORAL CONTRACEPTION; PREGNANCY; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PROTHROMBIN DEFICIENCY; STROKE; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HEMOSTASIS; HUMANS; PROGESTINS; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 84860434317     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.02.042     Document Type: Article

References (53)

1. S.O. Skouby Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries Eur J Contracept Reprod Health Care 9 2004 57 68
2. R. Rivera, I. Yacobson, and D. Grimes The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices Am J Obstet Gynecol 181 1999 1263 1269
3. D.R. Mishell Jr., O.A. Kletzky, P.F. Brenner, S. Roy, and J. Nicoloff The effect of contraceptive steroids on hypothalamic-pituitary function Am J Obstet Gynecol 128 1977 60 74
4. G. Benagiano, F.M. Primiero, and M. Farris Clinical profile of contraceptive progestins Eur J Contracept Reprod Health Care 9 2004 182 193
5. B.B. Gerstman, T.P. Gross, D.L. Kennedy, R.C. Bennett, D.K. Tomita, and B.V. Stadel Trends in the content and use of oral contraceptives in the United States 1964-88 Am J Public Health 81 1991 90 96
6. R.A. Edgren, and F.Z. Stanczyk Nomenclature of the gonane progestins Contraception 60 1999 313
7. R. Sitruk-Ware New progestagens for contraceptive use Hum Reprod Update 12 2006 169 178
8. I. Martinelli Counselling women about hormonal therapy Thromb Res 123 Suppl. 2 2009 574 578
9. A. Blanco-Molina, J. Trujillo-Santos, and R. Tirado Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry Thromb Haemost 101 2009 478 482
10. L.A. Heinemann, and J.C. Dinger Range of published estimates of venous thromboembolism incidence in young women Contraception 75 2007 328 336
11. T. Battaglioli, and I. Martinelli Hormone therapy and thromboembolic disease Curr Opin Hematol 14 2007 488 493
12. G. Tans, J. Curvers, and S. Middeldorp A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways Thromb Haemost 84 2000 15 21
13. A.A. Yuzpe, and W.J. Lancee Ethinyl estradiol and dl-norgestrel as a postcoital contraceptive Fertil Steril 28 1977 932 936
14. S.R. Lake, and S.A. Vernon Emergency contraception and retinal vein thrombosis Br J Ophthalmol 82 1998 538 542
15. C. Vasilakis, S.S. Jick, and H. Jick The risk of venous thromboembolism in users of postcoital contraceptive pills Contraception 59 1999 79 83
16. M. van Rooijen, A. Silveira, and S. Thomassen Rapid activation of haemostasis after hormonal emergency contraception Thromb Haemost 97 2007 15 20
17. A.E. Schindler Differential effects of progestins on hemostasis Maturitas 2003 S31 S37
18. U.H. Winkler Effects on haemostatic variables of desogestrel and gestodene-containing oral contraceptives in comparison with levonorgestrel- containing oral contraceptives: A review Am J Obstet Gynecol 179 1998 41 61
19. H. Kuhl Effects of progestin on hemostasis Maturitas 24 1996 1 19
20. U.H. Winkler, H. Howie, K. Bühler, T. Korver, T.B. Geurts, and H.J. Coelingh Bennink A randomized controlled double-blind study of effects on hemostasis of two progesterone-only pills containing 75 μ desogestrel or 30 μ levonorgestrel Contraception 57 1999 385 392
21. S. Sidney, D.B. Petitti, G.A. Soff, D.L. Cundiff, K.K. Tolan, and C.P. Quesenberry Jr. Venous thromboembolic disease in users of low-oestrogen combined oestrogen-progestin oral contraceptives Contraception 70 2004 3 10
22. A. van Hylckama Vlieg, F.M. Helmerhorst, J.P. Vandenbroucke, C.J. Doggen, and F.R. Rosendaal The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study BMJ 339 2009 b2921
23. M. Sakuma, M. Nakamura, and T. Takahashi Pulmonary embolism is an important cause of death in young adults Circ J 71 2007 1765 1770
24. E. Samuelsson, K. Hedenmalm, and I. Persson Mortality from venous thromboembolism in young Swedish women and its relation to pregnancy and use of oral contraceptives-an approach to specifying rates Eur J Epidemiol 20 2005 509 516
25. L. Parkin, D.C. Skegg, M. Wilson, G.P. Herbison, and C. Paul Oral contraceptives and fatal pulmonary embolism Lancet 355 2000 2133 2134
26. World Health Organization CSoCDaSHC Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Contraception 57 1998 315 324
27. C. Vasilakis, H. Jick, and M. del Mar Melero-Montes Risk of idiopathic venous thromboembolism in users of progestagens alone Lancet 354 1999 1610 1611
28. L.A. Heinemann, A. Assmann, T. DoMinh, and E. Garbe Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women Eur J Contracept Reprod Health Care 4 1999 67 73
29. Ø. Lidegaard, B. Edström, and S. Kreiner Oral contraceptives and venous thromboembolism: a five-year national case-control study Contraception 65 2002 187 196
30. A. Bergendal, V. Odlind, I. Persson, and H. Kieler Limited knowledge on progestogen-only contraception and risk of venous thromboembolism Acta Obstet Gynecol Scand 88 2009 261 266
31. J. Conard, G. Plu-Bureau, N. Bahi, M.H. Horellou, C. Pelissier, and J.C. Thalabard Progestogen-only contraception in women at high risk of venous thromboembolism Contraception 70 2004 437 441
32. I. Martinelli Thromboembolism in women Semin Thromb Hemost 32 2006 709 715
33. M.K. Barsoum, J.A. Heit, A.A. Ashrani, C.L. Leibson, T.M. Petterson, and K.R. Bailey Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study Thromb Res 126 2010 373 378
34. A. van Hylckama Vlieg, F.M. Helmerhorst, and F.R. Rosendaal The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device Arterioscler Thromb Vasc Biol 30 2010 2297 2300
35. Ø. Lidegaard, E. Lokkegaard, A.L. Svendsen, and C. Agger Hormonal contraception and risk of venous thromboembolism: national follow-up study BMJ 339 2009 b2890
36. Ø. Lidegaard, L.H. Nielsen, C.W. Skovlund, F.E. Skjeldestad, and E. Lokkegaard Risk of venous thromboembolism from use of oral contraceptives containing different progestogen and oestrogen doses: Danish cohort study, 2001-9 BMJ 25 343 2011 d6423
37. J. Aznar, A. Vaya, and A. Estelles Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives Haematologica 85 2000 1271 1276
38. F.R. Rosendaal, C.J. Doggen, and A. Zivelin Geographic distribution of the 20210 G to A prothrombin variant Thromb Haemost 79 1998 706 708
39. J. Conard, M.H. Horellou, P. van Dreden, T. Lecompte, and M. Samama Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women Thromb Haemost 63 1990 319 320
40. I. Pabinger, and B. Schneider Thrombotic risk in hereditary antithrombin III, protein C and protein S deficiency Arterioscler Thromb Vasc Biol 16 1996 742 748
41. A. Gerhardt, R.E. Scharf, and M.W. Beckmann Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium N Engl J Med 342 2000 374 380
42. I. Martinelli, V. de Stefano, E. Taioli, K. Paciaroni, E. Rossi, and P.M. Mannucci Inherited thrombophilia and first venous thromboembolism during pregnancy and puerpuerium Thromb Haemost 87 2002 791 795
43. P. Simioni, B.J. Sanson, and P. Prandoni Incidence of venous thromboembolism in families with inherited thrombophilia Thromb Haemost 81 1999 198 202
44. E. Grandone, M. Margaglione, and D. Colaizzo Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations Am J Obstet Gynecol 179 1998 1324 1328
45. A.P. Mohllajee, K.M. Curtis, S.L. Martins, and H.B. Peterson Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review Contraception 73 2006 166 178
46. J.P. Vandenbroucke, T. Koster, E. Briet, P.H. Reitsma, R.M. Bertina, and F.R. Rosendaal Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Ledien mutation Lancet 344 1994 1454 1457
47. J.P. Vandenbroucke, F. van der Meer, F.M. Helmerhorst, and F.R. Rosendaal Factor V Leiden: should we screen oral contraceptive users and pregnant women? BMJ 313 1996 1127 1130
48. M.P. Gomes, and S.R. Deitcher Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review Arch Intern Med 164 2004 1965 1976
49. J.E. Dietrich, and S.P. Hertweck Thrombophilias in adolescents: the past, present and future Curr Opin Obstet Gynecol 20 2008 470 474
50. C.N. Pisoni, M.J. Cuadrado, M.A. Khamashta, and B.J. Hunt Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil) Lupus 15 2006 877 880
51. M. Sönmezer, C. Atabekoǧlu, B. Cengiz, F. Dökmeci, and S.D. Cengiz Depot-medroxyprogesterone acetate in anticoagulated patients with previous hemorrhagic corpus luteum Eur J Contracept Reprod Health Care 10 2005 9 14
52. J. Ellison, A.J. Thomson, I.A. Greer, and I.D. Walker Drug Points: Apparent interaction between warfarin and levonorgestrel used for emergency contraception BMJ 321 2000 1382
53. World Health Organization Medical eligibility criteria for contraceptive use 3aed 2004 World Health Organization Geneva, Switzerland